Skip to main content
. 2019 Dec 11;5(2):202–207. doi: 10.1001/jamacardio.2019.4665

Figure. Changes in N-terminal Pro–b-Type (NT-proBNP) From Baseline Over 12 Weeks.

Figure.

This figure displays changes in NT-proBNP by randomized treatment arm during the double-blind period (weeks 0-8) and the open-label extension study (weeks 8-12; gray box). The vertical lines indicate 95% CIs and the dotted line represents patients switching from taking sacubitril/valsartan (S/V) after the week 8 visit.